Shankar Suma P, Fallurin Reshmitha, Watson Tonya, Shankar Prabhu R, Young Terri L, Orel-Bixler Deborah, Rauen Katherine A
Department of Pediatrics, University of California Davis, Sacramento, California, USA.
Department of Ophthalmology, University of California Davis, Sacramento, California, USA.
Ophthalmic Genet. 2022 Feb;43(1):48-57. doi: 10.1080/13816810.2021.1978103. Epub 2021 Oct 6.
Costello syndrome (CS) is a multisystem developmental disorder caused by germline pathogenic variants in resulting in dysregulation of the Ras pathway. A systematic characterization of ophthalmic manifestations provides a unique opportunity to understand the role of Ras signal transduction in ocular development and guide optimal ophthalmic care in CS individuals.
Visual function, ocular features and genotype/phenotype correlations were evaluated in CS individuals harboring pathogenic variants, by cross-sectional and retrospective studies, and were recruited through the Costello Syndrome Family Network (CSFN) between 2007 and 2020.
Fifty-six molecularly diagnosed CS individuals including 34 females and 22 males, ages ranging from 0.5 to 37 years were enrolled. The most common ophthalmic manifestations in the cross-sectional study were lack of stereopsis (96%), refractive errors (83%), strabismus (72%), nystagmus (69%), optic nerve hypoplasia or pallor (55%) and ptosis (13.7%) with higher prevalence than in the retrospective data (refractive errors (41%), strabismus (44%), nystagmus (26%), optic nerve hypoplasia or pallor (7%) and ptosis (11%)). Visual acuities were found to ranged from 20/25 to 20/800 and contrast sensitivity from 1.6% to 44%. pathogenic variants included p.G12S (84%), p.G13C (7%), p.G12A (5.4%), p.G12C (1.8%) and p.A146V (1.8%).
Majority of individuals with CS have refractive errors, strabismus, nystagmus, absent stereopsis, and optic nerve abnormalities suggesting that and the Ras pathway play a vital role in visual system development. Ptosis, refractive errors and strabismus are amenable to treatment and early ophthalmic evaluation is crucial to prevent long-term vision impairment and improve overall quality of life in CS.
科斯特洛综合征(CS)是一种多系统发育障碍,由 中的生殖系致病变异引起,导致Ras信号通路失调。对眼部表现进行系统特征分析为了解Ras信号转导在眼部发育中的作用以及指导CS患者的最佳眼科护理提供了独特机会。
通过横断面研究和回顾性研究,对携带 致病变异的CS患者的视觉功能、眼部特征以及基因型/表型相关性进行评估,这些患者于2007年至2020年间通过科斯特洛综合征家庭网络(CSFN)招募。
纳入了56例经分子诊断的CS患者,其中包括34名女性和22名男性,年龄在0.5至37岁之间。横断面研究中最常见的眼部表现为缺乏立体视觉(96%)、屈光不正(83%)、斜视(72%)、眼球震颤(69%)、视神经发育不全或苍白(55%)和上睑下垂(13.7%),其患病率高于回顾性数据(屈光不正(41%)、斜视(44%)、眼球震颤(26%)、视神经发育不全或苍白(7%)和上睑下垂(11%))。发现视力范围为20/25至20/800,对比敏感度为1.6%至44%。 致病变异包括p.G12S(84%)、p.G13C(7%)、p.G12A(5.4%)、p.G12C(1.8%)和p.A146V(1.8%)。
大多数CS患者有屈光不正、斜视、眼球震颤、缺乏立体视觉和视神经异常,这表明 和Ras信号通路在视觉系统发育中起重要作用。上睑下垂、屈光不正和斜视可进行治疗,早期眼科评估对于预防CS患者的长期视力损害和提高整体生活质量至关重要。